Stanford University
-
Study On Teen Mental Health App Shows High Engagement, Positive Impact
A study on BeMe Health, a behavioral health platform for teens, found that users engaged with the platform eight times on average over a month. The study was done in collaboration with Stanford University.
-
Stanford study: 30% of opioid-naive Medicaid patients develop a dependency after prescription
A new Stanford study revealed that among Medicaid patients who had never taken an opioid, 30% developed an opioid dependency following their first prescription. The research showed that opioids that have historically marketed as “safe,” such as tramadol, actually carry quite a high addiction risk for vulnerable populations.
-
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
-
Cancer biotech Pheast unveils $76M to expand immunotherapy’s menu to new targets
Biotech startup Pheast Therapeutics is out of stealth taking a tack similar to that of cancer immunotherapy company Forty Seven, also a spinout from the Stanford University lab of Irving Weissman. While both companies get immune cells to eat tumors, Pheast’s technology has the potential to take the approach to a broader range of cancer types including those that have historically resisted immunotherapy.
-
Startups, Devices & Diagnostics, Events, Policy
From campus to consumer: Lessons on university tech transfer
A panel at the WSGR Medical Device Conference in San Francisco delved into the specifics around what oftentimes sinks the relationship between companies and colleges and how to create real alignment and understanding between the two stakeholders.
-
What’s behind sky-high valuations of biopharma startups?
It was a banner year for biopharma, with records broken in deal values, number of exited unicorns and the biggest-ever biotech IPO. But where do these unicorn valuations come from?
-
Health unicorns’ valuations often outweigh their body of peer-reviewed research, study finds
Peer review is important for ensuring transparency and trust and may have put a stop to Theranos before it became a darling of investors and the press, the lead study author said in an interview.
-
Silicon Valley startup Univfy is bringing machine learning to fertility treatments
The company uses machine learning-based analysis of clinical data to help fertility clinics provide personalized patient reports with success probabilities for potential IVF participants.
-
At Stanford MedicineX a DIY diabetes e-patient becomes study PI
At the Stanford Medicine X conference, Dana Lewis, a vocal diabetes e-patient announced a research study funded by Robert Wood Johnson Foundation that she leads as principal investigator.
-
What can be done to improve mobile apps for cancer survivors?
Few of the hundreds of mobile apps for cancer survivors were appropriately developed or tested, according to a new study by researchers from the Cancer Prevention Institute of California.
-
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
-
Healthcare’s future: Mad Max or Star Trek
Exponential advances in health and other technologies have both deep risk and reward and the choices we make will create the future.
-
Can a smartphone-enabled testing platform make DIY urine tests more accurate?
The researchers’ next goal is to make a more integrated system so that the processing is done on the phone so the user can see the results as soon as testing is done.
-
Devices & Diagnostics, Startups
Stealth Stanford spinout Cala Health raises $18M for wearable device that treats hand and wrist tremors
Cala Health, a Stanford spinout operating in stealth, has raised $18 million – seemingly to advance its wearable technology that treats hand and wrist tremors.
-
Researchers in Oregon are changing the face of gene therapy with new breakthrough
Researchers at Oregon Health and Science University and Stanford University have found that there is a protein common in the majority of cells that transports genetic material from a cell’s outer wall to the interior – a breakthrough in gene therapy.
-
OrbiMed-backed LogicBio raises $4M for hemophilia gene therapy
Fledgling startup LogicBio Therapeutics has raised $4 million from OrbiMed Advisors for its hemophilia gene therapy therapeutic candidate.
Promoted
Payer’s Place: Dr. Anil Singh
Dr. Anil Singh shares his insights into the strategies employed by the organization to identify the most effective digital solutions for their members.
Promoted
Discover the Next-Gen Platform for Integrated Collaborative Care
Beyond EHRs and digital front doors, reducing the gaps in patient care journeys.
